Lv51
950 积分 2025-10-15 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
29分钟前
待确认
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
6个月前
已完结
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
8个月前
已完结
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy
9个月前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
9个月前
已完结
Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations
9个月前
已完结
Trends in gene therapy delivery technologies
11个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1年前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1年前
已完结